Renal artery stenting for atherosclerotic renal artery stenosis: A review of contemporary data

Figure 2 Flow diagram for deciding which patients to stent for ischemic nephropathy. When a patient is found to have worsening kidney function thought to be related to renal artery disease, the first step is a duplex ultrasound. If this shows elevated peak systolic velocities and renal-aortic ratios, the next step becomes evaluating the health of the kidney parenchyma. This is done by measuring either proteinuria or urine albumin to creatinine ratio. ¹It remains unclear what a good cutoff value for these lab tests is but urine albumin to creatinine ratio < 30 mg/g or proteinuria < 1 g per day would indicate healthy parenchyma. Next evaluate for rapidly declining kidney function (RDKF) with glomerular filtration rate trended over the last year. If RDKF is present, then renal angiography is indicated. Without RDKF, stenting is likely unnecessary. If angiography shows a renal artery stenosis ≥ 90% in a patient with a single functioning kidney (congenitally/surgically absent or atrophic contralateral kidney) or in bilateral renal arteries, then stenting is indicated. If the stenosis is ≤ 90% stenting is likely unnecessary. If there is a ≥ 90% stenosis unilaterally in a patient with two functioning kidneys then stenting can be performed but should involve the interventionalists’ clinical judgement about the individual case. RAS: Renal artery stenosis; PSV: Peak systolic velocity; RAR: Renal-aortic ratio; UACR: Urine albumin to creatinine ratio; RDKF: Rapidly declining kidney function; SFK: Single functioning kidney.